NCT07068958: A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
- State
- Not started
- Phase
- Phase 2
- People
- 200 planned
- Started
- 1 Aug 2025
- Primary completion
- 1 Nov 2025
- Arms
- 0.25% RCI001 Ophthalmic Solution BID, 0.25% RCI001 Ophthalmic Solution QID
- Results
- None posted
- 16 Jul 2025: Trial registered